Tilaknagar Industries Ltd. announced that its Board of Directors approved the Unaudited Financial Results for the quarter and nine months ending December 31, 2025, on February 13, 2026. The results, which include both consolidated and standalone figures, were reviewed by statutory auditors, M/s. Harshil Shah & Company, who provided a qualified conclusion. Key corporate actions during the period included the acquisition of the Imperial Blue Business Division and preferential allotment of shares and warrants.
Board Meeting Outcome and Financial Results Approval
The Board of Directors of Tilaknagar Industries Ltd. convened on Friday, February 13, 2026, between 02:46 P.M. and 04:35 P.M. The primary outcome was the consideration and approval of the Unaudited Financial Results (Consolidated and Standalone) for the quarter and nine months ended December 31, 2025. These results, along with the limited review reports from the Statutory Auditors, M/s. Harshil Shah & Company, have been submitted.
Key Financial Highlights (Consolidated)
The consolidated results revealed significant activity for the nine months ending December 31, 2025, compared to the previous year:
- Total Revenue from operations for the nine months reached ₹3,23,247.13 lacs.
- Profit/(Loss) for the period attributable to Owners of the Company stood at ₹3,577.67 lacs.
- Total Comprehensive Income attributable to Owners of the Company was ₹3,806.76 lacs.
For the quarter ended December 31, 2025:
- Revenue from operations was ₹1,45,301.28 lacs.
- Profit/(Loss) for the period attributable to Owners of the Company was a loss of (₹10,281.82 lacs).
- Total Comprehensive Income/(Loss) attributable to Owners of the Company resulted in a loss of (₹10,281.82 lacs).
Significant Corporate Events During the Period
The period saw several major strategic transactions:
Imperial Blue Business Division Acquisition
The Company completed the acquisition of the Imperial Blue business division (“IB”) from Pernod Ricard India Private Limited (“PRI”) on December 01, 2025, following approval from the Competition Commission of India (CCI) on October 07, 2025. The transaction involved a lump-sum cash consideration of Rs. 3,442 crores, plus a deferred consideration of EUR 28 million (approx. Rs. 290 crores). Acquisition-related costs amounting to Rs. 169.42 crores were recognized as Exceptional Items in the results.
Preferential Issuance
During the quarter ended September 30, 2025, the Company made significant capital raises:
- Equity Shares: Allotted 1,43,80,000 shares at a price of Rs. 382/- per share (including premium), aggregating to Rs. 5,49,31,60,000/-.
- Convertible Warrants: Issued 4,57,15,000 Warrants at Rs. 382/- per warrant, aggregating to Rs. 1,746,31,30,000/-. The company received Rs 15,43,75,75,000/- for these warrants by December 31, 2025.
Auditor’s Qualified Conclusion and Notes
The Statutory Auditors issued a qualified conclusion primarily due to the lack of impairment assessment for one ENA plant, as required under Ind AS 36. Management holds the belief that no impairment exists as the company plans to restart the plant post capital expenditure.
Furthermore, the auditors noted that the interim financial statements of 5 subsidiaries (total revenue of Rs 360.39 lakhs for the quarter) were reviewed by other auditors, and the conclusion on the consolidated statement relies solely on their reports.
Standalone Financial Performance Summary
The standalone results for the nine months ended December 31, 2025, showed a Profit/(Loss) Before Tax of ₹3,743.88 lacs. Earnings Per Share (Basic) for the nine months was 1.83 per share, compared to 7.90 in the previous year’s corresponding period.
The notes also mention that the Central Government enacted the New Labour Codes effective from November 21, 2025, and the company has assessed and accounted for the incremental impact based on current visibility.
Source: BSE
